-
1
-
-
0003157216
-
Loss of dopaminergic cells leads to Parkinson's disease
-
Kandell ER, Schwartz JH, Jessell TM (eds): New York, NY, Elsevier Science Publishing Co
-
Cote L, Crutcher MD: Loss of dopaminergic cells leads to Parkinson's disease, in Kandell ER, Schwartz JH, Jessell TM (eds): Principles of Neural Science. New York, NY, Elsevier Science Publishing Co, 1991, pp 645-659.
-
(1991)
Principles of Neural Science
, pp. 645-659
-
-
Cote, L.1
Crutcher, M.D.2
-
2
-
-
0026728285
-
Transplantation in the treatment of paralysis agitans (Parkinson's disease)
-
Fazzini E: Transplantation in the treatment of paralysis agitans (Parkinson's disease). JAOA 1992;92:1255-1266.
-
(1992)
JAOA
, vol.92
, pp. 1255-1266
-
-
Fazzini, E.1
-
4
-
-
0026578521
-
Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease
-
Fazzini E, Fleming J, Fahn S: Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 1992;7:153-158.
-
(1992)
Mov Disord
, vol.7
, pp. 153-158
-
-
Fazzini, E.1
Fleming, J.2
Fahn, S.3
-
5
-
-
0025200313
-
Do environmental toxins cause Parkinson's disease? a critical review
-
Tanner CM, Langsten JW: Do environmental toxins cause Parkinson's disease? A critical review. Neurology 1990;(suppl 3):17-30.
-
(1990)
Neurology
, Issue.3 SUPPL.
, pp. 17-30
-
-
Tanner, C.M.1
Langsten, J.W.2
-
6
-
-
0026740057
-
New insights into the cause of Parkinson's disease
-
Jenner P, Schaipira AHV, Marsden CD: New insights into the cause of Parkinson's disease. Neurology 1992;42:2241-2250.
-
(1992)
Neurology
, vol.42
, pp. 2241-2250
-
-
Jenner, P.1
Schaipira, A.H.V.2
Marsden, C.D.3
-
7
-
-
0025242960
-
Oxidative reactions in Parkinson's disease
-
Olanow CW: Oxidative reactions in Parkinson's disease. Neurology 1990;40(suppl 3):32-39.
-
(1990)
Neurology
, vol.40
, Issue.3 SUPPL.
, pp. 32-39
-
-
Olanow, C.W.1
-
8
-
-
0026466358
-
Initiating treatment of Parkinson's disease
-
Koller WC: Initiating treatment of Parkinson's disease. Neurology 1992;42(suppl 1):33-38.
-
(1992)
Neurology
, vol.42
, Issue.1 SUPPL.
, pp. 33-38
-
-
Koller, W.C.1
-
9
-
-
0026461370
-
The use of Sinemet CR in the management of mild to moderate Parkinson's disease
-
Rodnitzky RL: The use of Sinemet CR in the management of mild to moderate Parkinson's disease. Neurology 1992;42(suppl 1):44-50.
-
(1992)
Neurology
, vol.42
, Issue.1 SUPPL.
, pp. 44-50
-
-
Rodnitzky, R.L.1
-
10
-
-
0004027995
-
-
New York, NY, Oxford Press
-
Cooper JR, Bloom FE, Roth RH: The Biochemical Basis of Neuropharmacology. New York, NY, Oxford Press, 1991, pp 328-331.
-
(1991)
The Biochemical Basis of Neuropharmacology
, pp. 328-331
-
-
Cooper, J.R.1
Bloom, F.E.2
Roth, R.H.3
-
11
-
-
0026590683
-
Dopaminergic agonists in the treatment of Parkinson's disease
-
Goetz CG, Diederich NJ: Dopaminergic agonists in the treatment of Parkinson's disease. Neurol Clin 1992;10:527-540.
-
(1992)
Neurol Clin
, vol.10
, pp. 527-540
-
-
Goetz, C.G.1
Diederich, N.J.2
-
12
-
-
0024457355
-
DATATOP: A multicenter controlled clinical trial in early Parkinson's disease
-
The Parkinson Study Group: DATATOP: A multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol 1989;46:1052-1060.
-
(1989)
Arch Neurol
, vol.46
, pp. 1052-1060
-
-
-
13
-
-
34447110557
-
The effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
-
The Parkinson Study Group: The effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 93;328:173-183.
-
N Engl J Med
, vol.93
, Issue.328
, pp. 173-183
-
-
-
14
-
-
0027972318
-
Does selegiline delay progression of Parkinson's disease? a critical re-evaluation of the DATATOP study
-
Ward CD: Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study. J Neurol Neurosurg Psychiatr 1994;57:217-220.
-
(1994)
J Neurol Neurosurg Psychiatr
, vol.57
, pp. 217-220
-
-
Ward, C.D.1
-
15
-
-
0028112386
-
A controlled trial of lazabemide in levodopa treated Parkinson's disease
-
The Parkinson Study Group: A controlled trial of lazabemide in levodopa treated Parkinson's disease. Arch Neurol 1994;51:342-347.
-
(1994)
Arch Neurol
, vol.51
, pp. 342-347
-
-
-
16
-
-
0028907570
-
Stereotactic ventral pallidotomy for Parkinson's disease
-
Dogali M, Fazzini E, Kolodny E, et al: Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 1995;45:753-761.
-
(1995)
Neurology
, vol.45
, pp. 753-761
-
-
Dogali, M.1
Fazzini, E.2
Kolodny, E.3
-
17
-
-
0026344507
-
Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism
-
Fazzini E, Dwork AJ, Blum C, et al: Stereotaxic implantation of autologous adrenal medulla into caudate nucleus in four patients with parkinsonism. Arch Neurol 1991;48:813-820.
-
(1991)
Arch Neurol
, vol.48
, pp. 813-820
-
-
Fazzini, E.1
Dwork, A.J.2
Blum, C.3
-
18
-
-
0026447667
-
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
-
Spencer DD, Robbins RJ, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992;327:1541-1548.
-
(1992)
N Engl J Med
, vol.327
, pp. 1541-1548
-
-
Spencer, D.D.1
Robbins, R.J.2
Naftolin, F.3
-
19
-
-
0026458624
-
Bilateral mesencephalic grafting in two patients with parkinsonism induced by MPTP
-
Widner H, Tetrud J, Rhencrona S, et al: Bilateral mesencephalic grafting in two patients with parkinsonism induced by MPTP. N Engl J Med 1992;327:1556-1563.
-
(1992)
N Engl J Med
, vol.327
, pp. 1556-1563
-
-
Widner, H.1
Tetrud, J.2
Rhencrona, S.3
-
20
-
-
0025850274
-
Genetically modified cells: Applications for intracerebral grafting
-
Gage FH, Kawaja MD, Fisher LJ: Genetically modified cells: Applications for intracerebral grafting. Trends Neurosci 1991;14:328-333.
-
(1991)
Trends Neurosci
, vol.14
, pp. 328-333
-
-
Gage, F.H.1
Kawaja, M.D.2
Fisher, L.J.3
-
21
-
-
0027399705
-
Long-term correction of rat model of Parkinson's disease by gene therapy
-
Jiao S, Gurevich V, Wolff JA: Long-term correction of rat model of Parkinson's disease by gene therapy. Nature 1993;362:450-453.
-
(1993)
Nature
, vol.362
, pp. 450-453
-
-
Jiao, S.1
Gurevich, V.2
Wolff, J.A.3
-
22
-
-
0026448258
-
Fetal tissue transplantation in Parkinson's disease
-
Fahn S: Fetal tissue transplantation in Parkinson's disease. N Engl J Med 1992;327:1589-1590.
-
(1992)
N Engl J Med
, vol.327
, pp. 1589-1590
-
-
Fahn, S.1
-
23
-
-
0026443974
-
Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease
-
Freed CR, Breeze RE, Rosenberg NL, et al: Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;327:1549-1555.
-
(1992)
N Engl J Med
, vol.327
, pp. 1549-1555
-
-
Freed, C.R.1
Breeze, R.E.2
Rosenberg, N.L.3
-
24
-
-
0026792824
-
Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms
-
Laitinen LV, Bergenheim T, Hariz MI: Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotact Funct Neurosurg 1992;58(1-4):14-21.
-
(1992)
Stereotact Funct Neurosurg
, vol.58
, Issue.1-4
, pp. 14-21
-
-
Laitinen, L.V.1
Bergenheim, T.2
Hariz, M.I.3
-
25
-
-
0028633622
-
Ventroposterolateral pallidotomy
-
Laitinen LV: Ventroposterolateral pallidotomy. Stereotact Funct Neurosurg 1994;62(1-4):41-52.
-
(1994)
Stereotact Funct Neurosurg
, vol.62
, Issue.1-4
, pp. 41-52
-
-
Laitinen, L.V.1
|